Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
151038-94-7
157503-18-9
40311-60-2
4856-87-5
1076198-37-2
170866-05-4
71350-16-8 | O-(1-Methyl-allyl)-hydroxylamine hydrochloride | AA00FCK3 | MFCD09838140
7022-92-6 | ANILINE (15N) | AA00FCUZ | MFCD00084195
69181-71-1 | 2-(1-Piperidinyl)propanoic acid | AA00FD0W | MFCD03856596
664992-04-5 | 7-(Difluoromethyl)-5-methyl-4,5,6,7-tetrahydro[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid | AA00FD56 | MFCD02243922
70155-52-1 | Baclofen-d4 (Major) | AA00FDBI | MFCD21363459
72369-89-2 | 5-O-Benzyl-d-ribose | AA00FDJE | MFCD00269932
70832-36-9 | Propyl 2-acetamido-2-deoxy-beta-d-glucopyranoside | AA00FDQR | MFCD08703887
72786-10-8 | BETA-FUNALTREXAMINE HYDROCHLORIDE | AA00FDZJ | MFCD10565941
679431-51-7 | (R)-3-Fluoropyrrolidine | AA00FEB6 | MFCD06738462
699-55-8 | Bicyclo[2.2.2]octane-1-carboxylic acid | AA00FF8N | MFCD00218755